• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Celsion Corp. (CLSN)

    -NasdaqCM
    2.39 Up 0.06(2.58%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:2.33
    Open:2.36
    Bid:1.90 x 1000
    Ask:N/A
    1y Target Est:7.33
    Beta:0.98
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.34 - 2.41
    52wk Range:2.30 - 4.74
    Volume:55,579
    Avg Vol (3m):76,161
    Market Cap:47.74M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLSN

    Comparison

    Symbol% ChgMkt Cap
    CLSNUp 2.58%47.74M
    BSDMDown 2.12%12.82M
    DCTHUp 0.50%12.85M
    MMSIUp 0.06%745.21M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):93.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.42
    Quarterly EPS Est (Dec-14) :-0.36
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback